Trials / Completed
CompletedNCT06129318
:Effects of Pharmaceutical Care in Stroke Patients
Investigation of the Effects of Pharmaceutical Care Provided by a Clinical Pharmacist on Stroke Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (actual)
- Sponsor
- Marmara University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of the 1-year pharmaceutical care program offered by the clinical pharmacist to the patients admitted to the neurology service with the diagnosis of stroke, on medication adherence, quality of life, and clinical outcomes of the patients.
Detailed description
The study was conducted as a parallel randomized controlled study in the Neurology Clinic of a University Hospital in Turkey. Patients were randomly assigned to intervention and usual care groups. While the patients in the usual care group are given routine health services by the neurologist during their hospitalization and for 1 year after discharge; In addition to these routine services, the intervention group was provided with pharmaceutical care by a clinical pharmacist during the same period. The study was always conducted by the same neurologist and clinical pharmacist. Patient medication adherence, quality of life, and clinical parameters were evaluated at the beginning of the study and at the 12th month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Clinical Pharmacist Led Pharmaceutical Care | Within the scope of pharmaceutical care, medication review services for past and current medication use were provided by the clinical pharmacist. The patients in the intervention group were given verbal information about the definition of stroke, symptoms, how to manage risk factors, and their medications by the clinical pharmacist on the day of discharge, in addition to the neurologist. Each patient in the intervention group had a scheduled meeting with the clinical pharmacist. During the 1-year follow-up the patient education given by the clinical pharmacist was repeated every 3 months. |
Timeline
- Start date
- 2021-03-10
- Primary completion
- 2022-04-30
- Completion
- 2023-04-30
- First posted
- 2023-11-13
- Last updated
- 2023-11-13
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06129318. Inclusion in this directory is not an endorsement.